Collegium Pharmaceutical, Inc. Accrued Income Taxes, Current
Collegium Pharmaceutical, Inc. (COLL) had Accrued Income Taxes, Current of $1.14 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current › Accrued Liabilities, Current
us-gaap:AccruedIncomeTaxesCurrent · last filed 2026-08-06
- 2026-06-30: Accrued Income Taxes, Current $1.14M.
- 2026-03-31: Accrued Income Taxes, Current $7.79M.
- 2025-12-31: Accrued Income Taxes, Current $3.30M.
- 2025-09-30: Accrued Income Taxes, Current $797.00K.
| Period end | Accrued Income Taxes, Current |
|---|---|
| 2026-06-30 | $1.14M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $7.79M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $3.30M 10-Q · filed 2026-08-06 |
| 2025-09-30 | $797.00K 10-Q · filed 2025-11-06 |
| 2025-06-30 | $328.00K 10-Q · filed 2025-08-07 |
| 2025-03-31 | $8.95M 10-Q · filed 2025-05-08 |
| 2024-12-31 | $8.53M 10-K · filed 2026-02-26 |
| 2024-09-30 | $1.07M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $532.00K 10-Q · filed 2024-08-08 |
| 2024-03-31 | $14.08M 10-Q · filed 2024-05-09 |
| 2023-12-31 | $2.14M 10-K · filed 2025-02-27 |
| 2022-03-31 | $2.04M 10-Q · filed 2022-05-10 |
| 2021-12-31 | $622.00K 10-K · filed 2023-02-23 |
| 2021-09-30 | $36.00K 10-Q · filed 2021-11-04 |
| 2021-06-30 | $104.00K 10-Q · filed 2021-08-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| IRONWOOD PHARMACEUTICALS INC (IRWD) | United States | $0.694B | 5.37 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |